Comparison of two population pharmacokinetic programs, NONMEM and P-PHARM, for tacrolimus
- PMID: 12483452
- DOI: 10.1007/s00228-002-0517-7
Comparison of two population pharmacokinetic programs, NONMEM and P-PHARM, for tacrolimus
Abstract
Objectives: To compare the population modelling programs NONMEM and P-PHARM during investigation of the pharmacokinetics of tacrolimus in paediatric liver-transplant recipients.
Methods: Population pharmacokinetic analysis was performed using NONMEM and P-PHARM on retrospective data from 35 paediatric liver-transplant patients receiving tacrolimus therapy. The same data were presented to both programs. Maximum likelihood estimates were sought for apparent clearance (CL/F) and apparent volume of distribution (V/F). Covariates screened for influence on these parameters were weight, age, gender, post-operative day, days of tacrolimus therapy, transplant type, biliary reconstructive procedure, liver function tests, creatinine clearance, haematocrit, corticosteroid dose, and potential interacting drugs.
Results: A satisfactory model was developed in both programs with a single categorical covariate--transplant type--providing stable parameter estimates and small, normally distributed (weighted) residuals. In NONMEM, the continuous covariates--age and liver function tests--improved modelling further. Mean parameter estimates were CL/F (whole liver) = 16.3 l/h, CL/F (cut-down liver) = 8.5 l/h and V/F = 565 l in NONMEM, and CL/F = 8.3 l/h and V/F = 155 l in P-PHARM. Individual Bayesian parameter estimates were CL/F (whole liver) = 17.9 +/- 8.8 l/h, CL/F (cut-down liver) = 11.6 +/- 8.8 l/h and V/F = 712 +/- 792 l in NONMEM, and CL/F (whole liver) = 12.8 +/- 3.5 l/h, CL/F (cut-down liver) = 8.2 +/- 3.4 l/h and V/F = 221 +/- 164 l in P-PHARM. Marked interindividual kinetic variability (38-108%) and residual random error (approximately 3 ng/ml) were observed. P-PHARM was more user friendly and readily provided informative graphical presentation of results. NONMEM allowed a wider choice of errors for statistical modelling and coped better with complex covariate data sets.
Conclusion: Results from parametric modelling programs can vary due to different algorithms employed to estimate parameters, alternative methods of covariate analysis and variations and limitations in the software itself.
Similar articles
-
Population pharmacokinetics of tacrolimus in adult kidney transplant recipients.Clin Pharmacol Ther. 2002 Dec;72(6):660-9. doi: 10.1067/mcp.2002.129304. Clin Pharmacol Ther. 2002. PMID: 12496747
-
Toward better outcomes with tacrolimus therapy: population pharmacokinetics and individualized dosage prediction in adult liver transplantation.Liver Transpl. 2003 Feb;9(2):130-7. doi: 10.1053/jlts.2003.50023. Liver Transpl. 2003. PMID: 12548506
-
Population pharmacokinetics of tacrolimus in whole blood and plasma in asian liver transplant patients.Clin Pharmacokinet. 2006;45(1):59-75. doi: 10.2165/00003088-200645010-00004. Clin Pharmacokinet. 2006. PMID: 16430311
-
Toward a robust tool for pharmacokinetic-based personalization of treatment with tacrolimus in solid organ transplantation: A model-based meta-analysis approach.Br J Clin Pharmacol. 2019 Dec;85(12):2793-2823. doi: 10.1111/bcp.14110. Epub 2019 Dec 17. Br J Clin Pharmacol. 2019. PMID: 31471970 Free PMC article.
-
Population kinetics and conditional assessment of the optimal dosage regimen using the P-PHARM software package.Anticancer Res. 1994 Nov-Dec;14(6A):2321-6. Anticancer Res. 1994. PMID: 7825966 Review.
Cited by
-
Variation in Tacrolimus Trough Concentrations in Liver Transplant Patients Undergoing Endoscopic Retrograde Cholangiopancreatography: A Retrospective, Observational Study.Front Pharmacol. 2020 Aug 19;11:1252. doi: 10.3389/fphar.2020.01252. eCollection 2020. Front Pharmacol. 2020. PMID: 32973503 Free PMC article.
-
Individualized dosing parameters for tacrolimus in the presence of voriconazole: a real-world PopPK study.Front Pharmacol. 2024 Sep 10;15:1439232. doi: 10.3389/fphar.2024.1439232. eCollection 2024. Front Pharmacol. 2024. PMID: 39318775 Free PMC article.
-
Pharmacokinetic/pharmacodynamic modelling of GnRH antagonist degarelix: a comparison of the non-linear mixed-effects programs NONMEM and NLME.J Pharmacokinet Pharmacodyn. 2004 Dec;31(6):441-61. doi: 10.1007/s10928-005-5911-1. J Pharmacokinet Pharmacodyn. 2004. PMID: 16222784
-
Evaluation of limited sampling methods for estimation of tacrolimus exposure in adult kidney transplant recipients.Br J Clin Pharmacol. 2011 Feb;71(2):207-23. doi: 10.1111/j.1365-2125.2010.03815.x. Br J Clin Pharmacol. 2011. PMID: 21219401 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources